Interview: Nkaki Matlala – Vice-Chairman of the Public Health Enhancement…
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
Working together to enhance health. No single sector in South Africa, whether public or private, can successfully confront the immense challenge of the quadruple burden of disease. It requires combined forces, shared vision and commitment to working together. The Minister of Health officially launched the Social Compact Forum on 8 November 2012. The launch of the Forum was applauded by government and the ANC, as an initiative that leads the way for cooperation between the public and private sectors.
Establishing a social compact in healthcare. To achieve this noble vision the Minister and participating private sector companies established a Social Compact Forum and the Public Health Enhancement Fund (PHEF). The Social Compact Forum which will interact with the Minister and the Public Health Enhancement Fund (PHEF) is a financing instrument established by the Social Compact.
The Public Health Enhancement Fund (PHEF) will be managed by the private sector through the establishment of a not for profit entity in accordance with the Companies Act. Collection and disbursement of funds will be for the benefit of transformative healthcare projects, to be jointly agreed to between the Minister and the private sector. Payments from the fund will be made directly to vendors or, in the case of projects, to the providers of services to the beneficiaries of the projects, as determined by the Board of the PHEF from time to time. The rationale for the fund is for private sectors to contribute in strengthening the health sector and to build trust between the public and private sector. The initiative also aims to leverage the funds within the private sector to maximise benefits for the types of projects envisaged, rather than adopting an individual or silo approach which results in a number of fragmented, smaller projects which do not necessarily have the impact that is required. Ultimately, it is envisaged that this institutionalised engagement will assist in shaping a better future healthcare system for all, regardless of whether they be from the private or public health sector. The funding formula has been developed by corporate lawyers, auditors and BBBEE consultants to ensure that the contributions into the fund are recognised under the Socio-Economic Development (SED) element of the BBBEE balanced scorecard. Empowerdex has confirmed this. The BBBEE Act and its balanced scorecard require companies to spend 1% of Net Profit after tax (NPAT) for maximal SED recognition. The funding formula for the PHEF requires 0,75% for participation in the Fund. This means that participants would contribute 75% of their required SED obligation into the fund. Participation in the initiative comes at no additional cost or earnings dilution, unless companies decide to exceed the 1% NPAT scorecard requirement. Contributing companies stand to benefit from an institutionalised engagement with government, through less fragmentation of SED activities and more efficient channelling of resources.
Contact:
Tel: 011 239 6734
Fax: 011 239 6018
Address:
Building 8, Healthcare Park,
Woodlands Drive, Woodmead, 2191
Web: www.phef.co.za
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
The CEO of Ascendis Health talks about their business model, being a long-term investment company that brings together healthy businesses in the healthcare industry, and how the diversification of their product…
Merck’s managing director for South Africa and general manager for Southeast Africa reveals why the company takes a long-term perspective when investing in African countries, helping to shape healthcare systems,…
The general manager of Novagen Pharma reveals how they are the second largest supplier of ARVs within the private South African market, how there is much room for the generics…
The country manager and Global Established Products Business Lead at Pfizer South Africa reveals how the private sector is committed to expanding healthcare for South Africans, why her ambition is…
The country manager of Dr. Reddy´s South Africa explains that while the perception of the quality of generics has improved in South Africa, there is still a long way to…
The CEO of NAPM reveals how the main challenge facing his members is the length of time needed to register a generic product, taking up to four years and acting…
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and in those three years,…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental…
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since…
See our Cookie Privacy Policy Here